We are live on ! Find out more
WC

Woodstock Corp Portfolio holdings

AUM $1.2B
1-Year Est. Return 26.37%
This Fund
S&P 500
This Quarter Est. Return
+10.11%
1 Year Est. Return
+26.37%
3 Year Est. Return
+96.13%
5 Year Est. Return
+140.78%
10 Year Est. Return
+511.59%
AUM
$614M
AUM Growth
+$40M
Cap. Flow
-$7.96M
Cap. Flow %
-1.3%
Top 10 Hldgs %
29.7%
Holding
164
New
2
Increased
37
Reduced
65
Closed
9

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$5.57M
2
IRM icon
Iron Mountain
IRM
+$626K
3
MMM icon
3M
MMM
+$589K
4
KYNB
Kyntra Bio
KYNB
+$490K
5
RTN
Raytheon Company
RTN
+$442K

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$9.2M
2
SLB icon
SLB Ltd
SLB
+$1.83M
3
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
+$1.01M
4
HAIN icon
Hain Celestial
HAIN
+$727K
5
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$605K

Sector Composition

Rank Sector Weight
1 Healthcare 24.16%
2 Technology 22.86%
3 Industrials 9.44%
4 Consumer Staples 8.89%
5 Communication Services 8.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FITB
126
Fifth Third Bancorp
FITB
$51.7B
$400K 0.07%
13,000
-125
-1% -$3.66K
VRNS icon
127
Varonis Systems
VRNS
$4.87B
$380K 0.06%
14,658
– –
HAIN icon
128
Hain Celestial
HAIN
$53.5M
$367K 0.06%
14,145
-30,430
-68% -$727K
UNP icon
129
Union Pacific
UNP
$175B
$365K 0.06%
2,020
– –
MRVL icon
130
Marvell Technology
MRVL
$189B
$336K 0.05%
12,637
– –
IJR icon
131
iShares Core S&P Small-Cap ETF
IJR
$111B
$332K 0.05%
3,959
– –
KMI icon
132
Kinder Morgan
KMI
$69.7B
$315K 0.05%
14,900
-9,600
-39% -$194K
CRBP icon
133
Corbus Pharmaceuticals
CRBP
$180M
$312K 0.05%
1,907
– –
VRRM icon
134
Verra Mobility
VRRM
$778M
$307K 0.05%
21,975
– –
AMZN icon
135
Amazon
AMZN
$2.94T
$298K 0.05%
3,220
– –
BMY.RT
136
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$273K 0.04%
+90,585
New +$236K
ES icon
137
Eversource Energy
ES
$27.1B
$254K 0.04%
2,986
– –
CTSH icon
138
Cognizant
CTSH
$25.6B
$244K 0.04%
3,934
– –
FCX icon
139
Freeport-McMoran
FCX
$95.5B
$234K 0.04%
17,841
– –
RMD icon
140
ResMed
RMD
$32.4B
$233K 0.04%
1,505
– –
XLK icon
141
State Street Technology Select Sector SPDR ETF
XLK
$122B
$229K 0.04%
5,000
– –
PTEN icon
142
Patterson-UTI
PTEN
$3.83B
$201K 0.03%
19,135
– –
KOS icon
143
Kosmos Energy
KOS
$1.47B
$92K 0.02%
16,112
– –
SIOX
144
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$83K 0.01%
+16,215
New +$89.9K
EPM icon
145
Evolution Petroleum
EPM
$127M
$79K 0.01%
14,496
– –
SDPI
146
DELISTED
Superior Drilling Products Inc.
SDPI
$66K 0.01%
80,524
– –
SWN
147
DELISTED
Southwestern Energy Company
SWN
$32K 0.01%
13,370
-2,200
-14% -$4.55K
JASN
148
DELISTED
Jason Industries, Inc.
JASN
$7K ﹤0.01%
18,335
– –
APA icon
149
APA Corp
APA
$12.9B
– –
-12,405
Closed -$318K
NBR icon
150
Nabors Industries
NBR
$1.23B
– –
-483
Closed -$45K
3 4 5
6
7

Similar funds

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
FCCPG
FountainVest China Capital Partners GP3 Grand Cayman, Cayman Islands $1.2B AUM 6.95% 1-Year Est. Return
MB
MidFirst Bank Oklahoma City, Oklahoma $1.21B AUM
AIM
Anchor Investment Management Columbia, South Carolina $1.2B AUM 17.33% 1-Year Est. Return
TIM
Tortoise Investment Management White Plains, New York $1.21B AUM 13.04% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.4% 1-Year Est. Return
CS
Central Securities New York $1.21B AUM 19.91% 1-Year Est. Return
CCM
Condor Capital Management Martinsville, New Jersey $1.2B AUM 13.18% 1-Year Est. Return

Woodstock Corp's Q4 2019 Portfolio in Review

As of Q4 2019, Woodstock Corp held 164 positions worth $614M, up 7% from $574M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Woodstock Corp's Q4 2019 filing shows 2 new, 37 increased, 65 reduced and 9 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 90,585 shares worth $273K. The largest sale was Celgene Corp, an estimated $9.2M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 24% a quarter earlier, followed by Technology and Industrials.

  • Woodstock Corp's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 90,585 shares worth $273K.
  • Woodstock Corp added most to Bristol-Myers Squibb in Q4 2019, an estimated $5.57M increase.
  • Woodstock Corp's biggest Q4 2019 reduction was SLB Ltd, cutting an estimated $1.83M.
  • Woodstock Corp fully exited Celgene Corp in Q4 2019, selling an estimated $9.2M.
  • Woodstock Corp's ten largest holdings make up 30% of its $614M portfolio in Q4 2019.
  • Woodstock Corp opened 2 new positions and closed 9 in Q4 2019.
  • Woodstock Corp's portfolio value rose 7% quarter-over-quarter to $614M.

Based on Woodstock Corp's 13F filing for Q4 2019, filed 13 Jan 2020.